Immunotherapy is also known as biologic therapy for cancer treatment. Immunotherapy is treatment which is carried out using certain parts of a person’s immune system to fight diseases such as cancer. Immunotherapy is can be done in two ways which includes either stimulating person’s own immune system to work harder or smarter to attack cancer cells or injecting immune system components, such as man-made immune system proteins to fight against cancer cells. Globally increasing instances of deaths due to cancer and growing population with cancer coupled with increasing awareness about cancer and various available treatments to cure cancer are major driving factors for the growth of cancer immunotherapy market.
This report identifies the
cancer immunotherapy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cancer immunotherapy market.
Globally North America dominated the market for cancer immunotherapy in 2015 with accounting for nearly half of the global market due to high awareness and reported instances of cancer in the region. North America is expected to continue its domination during the period of study and was followed by Europe and Asia-Pacific as the second and third largest markets respectively in 2015. However Asia-Pacific is expected to be the fastest growing market due to technological advancement in the field of medical science, increasing medical tourism, increased healthcare expenditure by many developing economies coupled with increasing awareness about cancer in the region.
This report on cancer immunotherapy also covers different type of various cancer treated and market size in various geographical regions.
- On the basis of cancer treated with cancer immunotherapy this report covers all the major cancer treated using cancer immunotherapy: Cancer monoclonal antibodies (Naked monoclonal antibodies and Conjugated monoclonal antibodies), Immune checkpoint inhibitors, Cancer vaccines, Non-specific immunotherapies and Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cancer immunotherapy in each of the region.
Sample Companies Profiled in this Report are:
- Bristol Mayer’s Squibb
- F. Hoffmann-La Roche
- Pfizer Inc
- Eli Lilly and Company